Vitrectomy Outcomes in Eyes with Tractional Diabetic Macular Edema.


Journal

Ophthalmic research
ISSN: 1423-0259
Titre abrégé: Ophthalmic Res
Pays: Switzerland
ID NLM: 0267442

Informations de publication

Date de publication:
2019
Historique:
received: 08 01 2018
accepted: 20 04 2018
pubmed: 26 11 2018
medline: 26 2 2019
entrez: 26 11 2018
Statut: ppublish

Résumé

To evaluate pars plana vitrectomy (PPV) outcomes in cases with tractional diabetic macular edema (tDME). We conducted a single-center retrospective study with a follow-up of 12 months. Forty-six eyes with tDME of 38 patients submitted to PPV between 2013 and 2015 were assessed. A standard PPV was performed and surgical outcomes were registered at the 3-, 6-, and 12-month follow-up. The baseline median best corrected visual acuity (BCVA) in ETDRS (Early Treatment Diabetic Retinopathy Study) letters and the median central foveal thickness (CFT) were 43.0 letters and 491.0 µm, respectively. At the 12-month follow-up, a median decrease in CFT of 232.7 µm was observed. A CFT < 300 µm was achieved in 65.2% of the cases (52.2% needing no further treatment); a BCVA improvement by ≥10 letters was achieved in 60.0%, but there was a decrease of ≥10 letters in 13.0% of the cases. DME recurrence was observed in 10.9% of the cases, with a median time of development after vitrectomy of 6 months. As a major postoperative complication, a macular hole was observed in 1 patient (2.1%). In our series, PPV for tDME induced an improvement in retinal thickening and visual outcome in more than 50% of the cases, with low recurrence rates and a low number of postoperative complications.

Identifiants

pubmed: 30472703
pii: 000489459
doi: 10.1159/000489459
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-99

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Bernardete Pessoa (B)

Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal, bbtpessoa@gmail.com.
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal, bbtpessoa@gmail.com.

David Afonso Dias (DA)

Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Pedro Baptista (P)

Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Constança Coelho (C)

Genetics Laboratory, Institute of Environmental Health, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

João Nuno Melo Beirão (JNM)

Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.

Angelina Meireles (A)

Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH